Skip to Content

CVS Health Corp CVS Stock Quote

| Rating as of

Morningstar‘s Stock Analysis CVS

Valuation
Currency in USD
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price

INVESTOR

5-Star Price

INVESTOR

Economic Moat

INVESTOR

Capital Allocation

INVESTOR

CVS Adding Home Health and Value-Based Care Capabilities With Signify Deal; Shares Undervalued

Julie Utterback, CFA Senior Equity Analyst

Analyst Note

| Julie Utterback, CFA |

Narrow-moat CVS Health announced the $8 billion acquisition of Signify Health, which we view as the first step in its acquisition strategy within care delivery. While we appreciate the benefits expected from the Signify acquisition, it does not change our view of the firm's moat or our $113 fair value estimate. CVS shares remain mildly undervalued.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics CVS

Company Profile CVS

Business Description

Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.

Contact
One CVS Drive
Woonsocket, RI, 02895
T +1 401 765-1500
Industry Healthcare Plans
Most Recent Earnings Jun 30, 2022
Fiscal Year End Dec 31, 2021
Employees 300,000

Related News CVS